Article
Palo Alto, Calif. - Connetics Corp., based here, plans to start clinicaltrials on a new acne drug that some reports say is "cosmetically elegant."
Guidelines, Testing, and Future Directions in Urticaria
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Novel RF and HIFES Device is Effective for Enhancing Facial Laxity Among Asian Patients
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Patricia Farris, MD, on AP31’s Anti-Aging Power
James Del Rosso, DO, on What’s New in the Medicine Chest